Anthrax :: HHS Cancels VaxGen’s Anthrax Vaccine Contract
VaxGen, Inc. (Pink Sheets: VXGN.PK) announced that the Department of Health and Human Services (HHS) has terminated for default the company’s contract to provide 75 million doses of a modern anthrax vaccine for civilian biodefense.